Meet Mark Zafereo, M.D.
Mark Zafereo, M.D., F.A.C.S.
Department of Head and Neck Surgery, Division of Surgery
About Dr. Zafereo
Dr. Mark Zafereo is a Professor of Head and Neck Surgery at MD Anderson Cancer Center in Houston, Texas. He is Section Chief of Head and Neck Endocrine Surgery and Associate Medical Director of the Head & Neck Center at MD Anderson Cancer Center. Dr. Zafereo holds national committee appointments for the American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, American Thyroid Association, International Thyroid Oncology Group, and American College of Surgeons. He leads several national multicenter clinical trials on neoadjuvant therapy followed by surgery for anaplastic and medullary thyroid cancers. He has published significantly on Thyroid and other Head & Neck cancers, speaking nationally and internationally. His clinical practice focuses on patients afflicted with thyroid cancer and parathyroid neoplasms.
In the News
Present Title & Affiliation
Primary Appointment
Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Section Chief, Department of Head and Neck Endocrine Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Adjunct Faculty Appointment, Baylor College of Medicine, Houston, TX
Education & Training
Degree-Granting Education
| 2005 | University of Texas Medical School, Houston, TX, USA, MD, Doctor of Medicine |
| 2001 | University of Texas, Austin, TX, USA, BBA, Finance |
Postgraduate Training
| 2020-2020 | LEADing Others Core Curriculum, University of Texas MD Anderson Cancer Center Leadership Institute, Houston, TX |
| 2010-2011 | Clinical Fellowship, Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX |
| 2007-2010 | Clinical Residency, Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX |
| 2005-2007 | Clinical Residency, Otolaryngology-Head and Neck Surgery, University of Texas Health Science Center, Houston, TX |
Board Certifications
| 2011 | American Board of Otolaryngology |
Experience & Service
Academic Appointments
Associate Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2021
Assistant Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2016
Clinical Specialist, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2011
Administrative Appointments/Responsibilities
Associate Medical Director, Head & Neck Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Associate Medical Director, Department of Endocrine Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2021
Director, Department of Department of Head and Neck Surgery International Visiting Scientist and Observer Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Faculty Oversight, Department of Head and Neck Survivorship Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2016
Back-up Moderator, Department of Weekly Multidisciplinary Head and Neck Planning Conference, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present
Institutional Committee Activities
Member, Endocrine Center Steering Committee, 2015 - Present
Member, MD Anderson Division of Surgery Cancer Network Operations Committee, 2014 - Present
Member, Endocrine Center Epic Specialty Content Validation Workgroup, 2014 - 2016
Member, Global Academic Programs Africa Steering Committee, 2012 - Present
Honors & Awards
| 2019 | MD Anderson Cancer Center Top Performer Award (based on Consumer Assessment of Healthcare Providers and Systems Top 10% nationally) |
| 2018 | MD Anderson Cancer Center Top Performer Award (based on Consumer Assessment of Healthcare Providers and Systems Top 10% nationally) |
| 2017 | MD Anderson Cancer Center Top Performer Award (based on Consumer Assessment of Healthcare Providers and Systems Top 1% nationally), The University of Texas MD Anderson Cancer Center |
| 2016 | American Academy of Otolaryngology-Head and Neck Surgery Nominating Committee Candidate |
| 2016 | Baylor College of Medicine Inaugural Donald T. Donovan Excellence in Resident Education Award |
| 2015 | American Academy of Otolaryngology-Head and Neck Surgery Honor Service Award |
| 2015 | American Academy of Otolaryngology-Head and Neck Surgery Young Physicians Spotlight |
| 2015 | Tanzanian ENT Society Honorary Member |
| 2015 | American Academy of Otolaryngology-Head and Neck Surgery Nominating Committee Candidate |
| 2014 | America's Top Physicians |
| 2013 | American Academy of Otolaryngology-Head and Neck Surgery Holt Leadership Award |
| 2013 | Texas Super Doctors |
| 2011 | American Academy of Otolaryngology-Head and Neck Surgery Foundation Spring Meeting Resident Leadership Grant |
| 2010 | American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting Resident Leadership Grant |
| 2010 | Global ENT Outreach Farhangi/Asdaghi Scholarship for International Medical Service Projects |
| 2010 | Houston Society of Otolaryngology-Head and Neck Surgery Research Award |
| 2010 | Texas Association of Otolaryngology Research Award |
| 2010 | Hitoshi Nikaidoh Memorial Humanitarian Grant |
| 2010 | American Academy of Otolaryngology-Head and Neck Surgery Humanitarian Grant |
| 2009 | American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting Resident Leadership Grant |
| 2009 | Combined Otolaryngology Society Meeting Distinguished Poster and American Head and Neck Society Presidential Citation |
| 2009 | Houston Society of Otolaryngology-Head and Neck Surgery Research Award |
| 2009 | Texas Association of Otolaryngology Research Award |
| 2009 | Houston Surgical Society Research Award |
| 2009 | American Association for Cancer Research Scholar-In-Training Award Finalist |
| 2008 | American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting Resident Leadership Grant |
| 2008 | American Head and Neck Society 7th International Conference on Head and Neck Cancer Grant |
| 2008 | American Academy of Otolaryngology-Head and Neck Surgery Foundation Board of Governors Resident Leadership Grant |
| 2008 | Houston Society of Otolaryngology-Head and Neck Surgery Research Award |
| 2007 | American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting Resident Leadership Grant |
| 2007 | Memorial Hermann Hospital Medical Humanitarian Grant |
| 2005 | Alpha Omega Alpha Honor Medical Society |
| 2002 | M.D. Anderson Cancer Center Summer Research Program Grant |
| 2001 | University of Texas Magna cum Laude, University Honors |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Wu SY, Chiang YJ, Fisher SB, Sturgis EM, Zafereo ME, Nguyen S, Grubbs EG, Graham PH, Lee JE, Waguespack SG, Perrier ND. Risks of Hypoparathyroidism After Total Thyroidectomy in Children: A 21-Year Experience in a High-Volume Cancer Center. World J Surg 44(2):442-451, 2020. e-Pub 2019. PMID: 31686157.
- Tran J, Zafereo ME. Segmental tracheal resection (nine rings) and reconstruction for carcinoma showing thymus-like differentiation (CASTLE) of the thyroid. Head Neck 41(9):3478-3481, 2019. e-Pub 2019. PMID: 31233256.
- Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo ME, Perrier N, Busaidy NL. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol 145(8):1977-1986, 2019. e-Pub 2019. PMID: 31309300.
- Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid 29(8):1036-1043, 2019. PMID: 31319771.
- Ting J, Bell D, Ahmed S, Ying A, Waguespack SG, Tu SM, Weber R, Zafereo ME. Primary Malignant Thyroid Teratoma: An Institutional Experience. Thyroid 29(2):229-236, 2019. PMID: 30759052.
- Tran J, Zafereo ME. Parapharyngeal Dissection for Papillary Thyroid Cancer. VideoEndocrinology 6(1), 2019. e-Pub 2019. PMID: 32025530.
- Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol 25(11):3380-3388, 2018. e-Pub 2018. PMID: 30022274.
- Jaber T, Waguespack SG, Cabanillas ME, Elbanan M, Vu T, Dadu R, Sherman SI, Amit M, Santos EB, Zafereo ME, Busaidy NL. Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine. J Clin Endocrinol Metab 103(10):3698-3705, 2018. e-Pub 2018. PMID: 30032208.
- Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions. Thyroid 28(10):1301-1310, 2018. e-Pub 2018. PMID: 30141373.
- Tam S, Amit M, Boonsripitayanon M, Busaidy NL, Cabanillas ME, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis EM, Zafereo ME. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid 28(8):982-990, 2018. e-Pub 2018. PMID: 29936892.
- Cabanillas ME, Ferrarotto R, Garden AS, Ahmed S, Busaidy NL, Dadu R, Williams MD, Skinner H, Gunn GB, Grosu H, Iyer P, Hofmann MC, Zafereo ME. Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Thyroid 28(7):945-951, 2018. e-Pub 2018. PMID: 29742974.
- Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo ME, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross N, Cabanillas ME. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer 6(1):68, 2018. e-Pub 2018. PMID: 29996921.
- Sakafu LL, Mselle TF, Mwaiselage JD, Maunda KK, Eddin BS, Zafereo ME. Thyroid Cancer and Iodine Deficiency Status: A 10-Year Review at a Single Cancer Center in Tanzania. OTO Open 2(2):2473974X18777238, 2018. e-Pub 2018. PMID: 30480218.
- Ahmed S, Ghazarian MP, Cabanillas ME, Zafereo ME, Williams MD, Vu T, Schomer DF, Debnam JM. Imaging of Anaplastic Thyroid Carcinoma. AJNR Am J Neuroradiol 39(3):547-551, 2018. e-Pub 2017. PMID: 29242360.
- Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Association of Lymph Node Density With Survival of Patients with Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 144(2):108-114, 2018. PMID: 29192312.
- Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo ME, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid 28(1):79-87, 2018. e-Pub 2017. PMID: 29161986.
- Christakis I, Silva AM, Williams MD, Garden A, Grubbs EG, Busaidy NL, Lee JE, Perrier ND, Zafereo ME. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol 7(6):e463-e470, 2017. e-Pub 2017. PMID: 28751227.
- Zafereo ME, Rao SN*, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, Gunn GB, Lu C, Ferrarotto R, Lai SY, Cabanillas ME. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid 27(5):672-681, 2017. e-Pub 2017. PMID: 28068873.
- Gitomer SA, Hutcheson KA, Christianson BL, Samuelson MB, Barringer DA, Roberts DB, Hessel AC, Weber RS, Lewin JS, Zafereo ME. Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture. Head Neck 38(12):1765-1771, 2016. e-Pub 2016. PMID: 27394060.
- Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo ME, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck 38(12):1739-1751, 2016. e-Pub 2016. PMID: 27466789.
- Kansara S, Bell D, Johnson J, Zafereo ME. Head and Neck Inflammatory Pseudotumor: case series and review of the literature. Neuroradiol J 29(6):440-446, 2016. e-Pub 2016. PMID: 27650653.
- Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, Frank SJ. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 96(1):30-41, 2016. e-Pub 2016. PMID: 27325480.
- Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 95(4):1117-31, 2016. e-Pub 2016. PMID: 27354127.
- Zafereo ME, Xu L, Dahlstrom KR, Viamonte CA, El-Naggar AK, Wei Q, Li G, Sturgis EM. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol 56:47-53, 2016. e-Pub 2016. PMID: 27086486.
- Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck 38 Suppl 1:E1962-8, 2016. e-Pub 2016. PMID: 26879395.
- Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo ME, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK. Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res 22(3):725-33, 2016. e-Pub 2015. PMID: 26631609.
- Cata JP, Zafereo ME, Villarreal J, Unruh BD, Truong A, Truong DT, Feng L, Gottumukkala V. Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. J Clin Anesth 27(8):672-9, 2015. e-Pub 2015. PMID: 26371714.
- Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response. Oral Oncol 51(2):195-201, 2015. e-Pub 2014. PMID: 25444304.
- Shehata M, Gombos D, Bishop J, Zafereo ME. Sinonasal melanoma arising from conjunctival primary acquired melanosis. BMJ Case Rep 2015, 2015. e-Pub 2015. PMID: 25694640.
- Gan SJ, Dahlstrom KR, Peck BW, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593-601, 2013. e-Pub 2013. PMID: 23605777.
- Peck BW, Dahlstrom KR, Gan SJ, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 35(6):794-9, 2013. e-Pub 2012. PMID: 22711172.
- Rosenberg TL, Kelley K, Dowdall JR, Replogle WH, Liu JC, Raol NP, Zafereo ME. Section for residents and fellows-in-training survey results. Otolaryngol Head Neck Surg 148(4):582-8, 2013. e-Pub 2013. PMID: 23396591.
- Xu L, Mugartegui L, Li G, Sarlis NJ, Wei Q, Zafereo ME, Sturgis EM. Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans. Mol Carcinog 51 Suppl 1:E 158-67, 2012. e-Pub 2012. PMID: 22415807.
- Zhang Y, Sturgis EM, Huang Z, Zafereo ME, Wei Q, Li G. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck. Cancer 118(2):485-92, 2012. e-Pub 2011. PMID: 21717430.
- Zhang Y, Sturgis EM, Zafereo ME, Wei Q, Li G. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Cancer 117(6):1227-35, 2011. e-Pub 2010. PMID: 21381012.
- Zafereo ME, Weber RS, Lewin JS, Roberts DB, Hanasono MM. Complications and functional outcomes following complex oropharyngeal reconstruction. Head Neck 32(8):1003-11, 2010. PMID: 19953614.
- Lei D, Sturgis EM, Wang LE, Liu Z, Zafereo ME, Wei Q, Li G. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 19(6):1484-91, 2010. e-Pub 2010. PMID: 20501759.
- Li F, Sturgis EM, Chen X, Zafereo ME, Wei Q, Li G. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer 116(10):2350-9, 2010. PMID: 20225330.
- Lei D, Sturgis EM, Liu Z, Zafereo ME, Wei Q, Li G. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis 31(2):222-7, 2010. e-Pub 2009. PMID: 19955391.
- Li F, Sturgis EM, Zafereo ME, Liu Z, Wang LE, Wei Q, Li G. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer 125(11):2660-5, 2009. PMID: 19585505.
- Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB, Weber RS. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 115(24):5723-33, 2009. PMID: 19760612.
- Chen LM, Li G, Reitzel LR, Pytynia KB, Zafereo ME, Wei Q, Sturgis EM. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila) 2(9):782-91, 2009. e-Pub 2009. PMID: 19737985.
- Zafereo ME, Sturgis EM, Liu Z, Wang LE, Wei Q, Li G. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis 30(6):997-1002, 2009. e-Pub 2009. PMID: 19369580.
- Zafereo ME, Sturgis EM, Aleem S, Chaung K, Wei Q, Li G. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila) 2(5):432-9, 2009. e-Pub 2009. PMID: 19401526.
- Zafereo ME, Taylor RJ, Pereira KD. Supraglottoplasty for laryngomalacia with obstructive sleep apnea. Laryngoscope 118(10):1873-7, 2008. PMID: 18641529.
- Zafereo ME, Pereira KD. Chronic retropharyngeal abscess presenting as obstructive sleep apnea. Pediatr Emerg Care 24(6):382-4, 2008. PMID: 18562883.
- Zafereo ME, Fakhri S, Prayson R, Batra PS, Lee J, Lanza DC, Citardi MJ. Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg 138(4):452-8, 2008. PMID: 18359353.
- Dahlstrom KR, Little JA, Zafereo ME, Lung M, Wei Q, Sturgis EM. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck 30(1):75-84, 2008. PMID: 17694557.
- Kaszuba SM, Zafereo ME, Rosenthal DI, El-Naggar AK, Weber RS. Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. Arch Otolaryngol Head Neck Surg 133(6):546-50, 2007. PMID: 17576904.
Invited Articles
- Guntinas-Lichius O, Volk GF, Olsen KD, Mäkitie AA, Silver CE, Zafereo ME, Rinaldo A, Randolph GW, Simo R, Shaha AR, Vander Poorten V, Ferlito A. Facial nerve electrodiagnostics for patients with facial palsy: a clinical practice guideline. Eur Arch Otorhinolaryngol 277(7):1855-1874, 2020. e-Pub 2020. PMID: 32270328.
- Rodrigo JP, Hernandez-Prera JC, Randolph GW, Zafereo ME, Hartl DM, Silver CE, Suárez C, Owen RP, Bradford CR, Mäkitie AA, Shaha AR, Bishop JA, Rinaldo A, Ferlito A. Parathyroid cancer: An update. Cancer Treat Rev 86:102012, 2020. e-Pub 2020. PMID: 32247225.
- Zafereo ME*, Jozaghi Y*, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
- MD Anderson Head and Neck Surgery Treatment Guidelines Consortium, Consortium members, Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, Gidley PW, Lewis CM, Diaz E, Goepfert RP, Kupferman ME, Gross ND, Hessel AC, Pytynia KB, Nader ME, Wang JR, Lango MN, Kiong KL, Guo T, Zhao X, Yao CMKL, Appelbaum E, Alpard J, Garcia JA, Terry S, Flynn JE, Bauer S, Fournier D, Burgess CG, Wideman C, Johnston M, You C, De Luna R, Joseph L, Diersing J, Prescott K, Heiberger K, Mugartegui L, Rodriguez J, Zendehdel S, Sellers J, Friddell RA, Thomas A, Khanjae SJ, Schwarzlose KB, Chambers MS, Hofstede TM, Cardoso RC, Wesson RA, Won A, Otun AO, Gombos DS, Al-Zubidi N, Hutcheson KA, Gunn GB, Rosenthal DI, Gillison ML, Ferrarotto R, Weber RS, Hanna EY, Myers JN, Lai SY. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck 42(6):1194-1201, 2020. e-Pub 2020. PMID: 32342541.
- Nixon IJ, Shah JP, Zafereo ME, Simo RS, Hay ID, Suárez C, Zbären P, Rinaldo A, Sanabria A, Silver C, Mäkitie A, Vander Poorten V, Kowalski LP, Shaha AR, Randolph GW, Ferlito A. The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective. Eur J Surg Oncol 46(5):754-762, 2020. e-Pub 2020. PMID: 31952928.
- Zbären P, Shah JP, Randolph GW, Silver CE, Olsen KD, Shaha AR, Zafereo ME, Kowalski LP, Suarez C, Sanabria A, Vander Poorten V, Nixon I, Rinaldo A, Ferlito A. Thyroid Surgery: Whose Domain Is It?. Adv Ther 36(10):2541-2546, 2019. e-Pub 2019. PMID: 31401787.
- Zafereo ME, Yu J, Angelos P, Brumund K, Chuang HH, Goldenberg D, Lango M, Perrier N, Randolph G, Shindo ML, Singer M, Smith R, Stack BC, Steward D, Terris DJ, Vu T, Yao M, Tufano RP. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck 41(7):2398-2409, 2019. e-Pub 2019. PMID: 31002214.
- Amit M, Boonsripitayanon M, Zafereo ME. ASO Author Reflections: Strap Muscle Invasion Does Not Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer. Ann Surg Oncol 25(Suppl 3):892-893, 2018. e-Pub 2018. PMID: 30264249.
- Gonçalves Filho J, Zafereo ME, Ahmad FI, Nixon IJ, Shaha AR, Vander Poorten V, Sanabria A, Hefetz AK, Robbins KT, Kamani D, Randolph GW, Coca-Pelaz A, Simo R, Rinaldo A, Angelos P, Ferlito A, Kowalski LP. Decision making for the central compartment in differentiated thyroid cancer. Eur J Surg Oncol 44(11):1671-1678, 2018. e-Pub 2018. PMID: 30145001.
- Schneider R, Randolph GW, Dionigi G, Wu CW, Barczynski M, Chiang FY, Al-Quaryshi Z, Angelos P, Brauckhoff K, Cernea CR, Chaplin J, Cheetham J, Davies L, Goretzki PE, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Orloff L, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Singer MC, Snyder SK, Tolley NS, Van Slycke S, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo ME, Dralle H. International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal. Laryngoscope 128 Suppl 3:S1-S17, 2018. e-Pub 2018. PMID: 30289983.
- Wu CW, Dionigi G, Barczynski M, Chiang FY, Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K, Brooks JA, Cernea CR, Chaplin J, Chen AY, Davies L, Diercks GR, Duh QY, Fundakowski C, Goretzki PE, Hales NW, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Miyauchi A, Orloff L, Rastatter JC, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Stack BC, Tolley NS, Slycke SV, Snyder SK, Urken ML, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo ME, Randolph GW. International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data. Laryngoscope 128 Suppl 3:S18-S27, 2018. e-Pub 2018. PMID: 30291765.
- Maniakas A, Davies L, Zafereo ME. Thyroid Disease Around the World. Otolaryngol Clin North Am 51(3):631-642, 2018. e-Pub 2018. PMID: 29548512.
- Fundakowski CE, Hales NW, Agrawal N, Barczynski M, Camacho PM, Hartl DM, Kandil E, Liddy WE, McKenzie TJ, Morris JC, Ridge JA, Schneider R, Serpell J, Sinclair CF, Snyder SK, Terris DJ, Tuttle RM, Wu CW, Wong RJ, Zafereo ME, Randolph GW. Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement. Head Neck 40(4):663-675, 2018. e-Pub 2018. PMID: 29461666.
- Cabanillas ME, Zafereo ME, Williams MD, Ferrarotto R, Dadu R, Gross N, Gunn GB, Skinner H, Cote G, Grosu HB, Iyer P, Busaidy NL. Recent advances and emerging therapies in anaplastic thyroid carcinoma. F1000Res 7(7), 2018. e-Pub 2018. PMID: 31583077.
- Cabanillas ME, Zafereo ME, Gunn GB, Ferrarotto R. Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy. J Oncol Pract 12(6):511-8, 2016. PMID: 27288464.
- Zafereo ME. Surgical salvage of recurrent cancer of the head and neck. Curr Oncol Rep 16(5):386, 2014. PMID: 24623521.
- Zafereo ME. Evaluation and staging of squamous cell carcinoma of the oral cavity and oropharynx: limitations despite technological breakthroughs. Otolaryngol Clin North Am 46(4):599-613, 2013. e-Pub 2013. PMID: 23910472.
Manuals, Teaching Aids, Other Teaching Publications
- . Key Leader Core Team, MDACC Head and Neck Surgery online cancer treatment algorithms Larynx Cancer, 2015.
- . Key Leader Core Team, MDACC Head and Neck Surgery online cancer treatment algorithms Oral Cavity Cancer, 2015.
- . Hypothyroidism after Head and Neck Radiation.
- Zafereo ME. Thyroid nodules, Cancers and Goiters, Developing World Clinical Guidelines for Head and Neck Cancer. African Head and Neck Society.
Other Articles
- Zafereo ME Chronic ear disease in Zanzibar. American Academy of Otolaryngology-Head and Neck Surgery-Bulletin(2):45, 2011.
- Zafereo ME The Next Generation of Head and Neck Surgeons: Opportunities and Challenges. American Academy of Otolaryngology-Head and Neck Surgery-Bulletin(1):24, 2011.
- Zafereo ME Microtia surgery in Honduras. Academy of Otolaryngology-Head and Neck Surgery-Bulletin(12):45, 2010.
- Zafereo ME 2010 Section for Residents and Fellows Survey; Thoughts from Our Residents. American Academy of Otolaryngology-Head and Neck Surgery-Bulletin(11):17, 2009.
Abstracts
- Sheu T, Garden AS, Fuller CD, Gunn GB, Nguyen T, Beadle BM, Morrison WH, Sio TT, Takiar V, Zafereo M, Rosenthal DI, Frank SJ, Phan J. Reirradiation Utilizing Proton Radiation Therapy May Improve Toxicity Free Survival in Patients With Small-Volume, Recurrent Head And Neck Cancer. Int J Radiat Oncol Biol Phys 96(2S):E331, 2016. PMID: 27674401.
- Mulcahy C, Mohamed AS, Weber R, Lai S, Fuller C, Rosenthal D, El-Naggar A, Hutcheson K, Gunn B, Garden A, Kies M, Lewin J, Morrison W, Zafereo M.. Comorbidity and Survival in Locally Advanced Laryngeal Cancer, 2016.
Book Chapters
- Lee M; Waguespack SG; Graham PH; Hu MI; Zafereo ME. Syndromic Medullary Thyroid Carcinoma: MEN 2A and MEN 2B. In: Surgical and Medical Management of Diseases of the Thyroid and Parathyroid. Plural Publishing, Inc, 371-390, 2020.
- Zafereo ME, Weber RS. Thyroid Cancer. In: Conn's Current Therapy 2018. Elsevier, 2019.
- Zafereo ME, et al. Thyroid. In: Operative Standards for Cancer Surgery: Volume 2: Esophagus, Melanoma, Rectum, Stomach, Thyroid. Wolters Kluwer; American College of Surgeons, 2019.
- George J, Mongkol B, Zafereo ME. Neck Mass and Hoarseness (papillary thyroid cancer). In: Case Studies in Otolaryngology- Head & Neck Surgery and Audiology, 2019.
- Mays A, Zafereo ME. Medullary Thyroid Carcinoma Office-Based Scenario. In: Case Studies in Otolaryngology- Head & Neck Surgery and Audiology, 2019.
- Lim M,Zafereo ME, Grubbs E. Locally advanced differentiated thyroid cancer. In: Management of Thyroid Nodules and Differentiated Thyroid Cancer: A Practical Guide. Springer, 2016.
- Zafereo ME, Weber RS. Thyroid Cancer. In: Conn's Current Therapy 2017. 69th edition. Elsevier, 2016.
- Zafereo ME, Beadle B, Weber RS. Carcinoma Of Oropharynx. In: Head and Neck Cancer Recurrence: Evidence-based Multidisciplinary Management. Thieme, 2012.
- Holsinger FC, Zafereo ME, Chung WY. Robotic Thyroidectomy: A Transaxillary Approach without CO2 Insufflation. In: Cohen & Clayman: Atlas of Head and Neck Surgery, 2011.
Grant & Contract Support
| Title: | Establishing Dietary Correlates of IGF-1 Ligand Expression in Cancer patients |
| Funding Source: | Riviera Country Club, Orland Park, Illinois |
| Role: | Collaborator |
| Title: | Lenvatinib in combination with pembrolizumab for stage IVB locally advanced and unresectable or stage IVC metastatic anaplastic thyroid cancer |
| Funding Source: | Merck MISP Program |
| Role: | Co-Principal Investigator |
| Title: | Neoadjuvant/Adjuvant Treatment with Selpercatinib in RET-Altered Thyroid Cancers |
| Funding Source: | Lilly USA |
| Role: | Principal Investigator |
| Title: | Pembrolizumab in combination with dabrafenib and trametinib as a neoadjuvant strategy prior to surgery therapy in BRAF-mutated anaplastic thyroid cancer |
| Funding Source: | Merck |
| Role: | Principal Investigator |